CRHM - CRH Medical Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
120,355
112,749
100,242
78,355
46,048
Cost of Revenue
94,210
86,102
79,313
49,733
27,473
Gross Profit
26,145
26,647
20,929
28,622
18,576
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
6,305
6,352
6,304
3,798
5,053
Total Operating Expenses
6,305
6,352
6,319
3,851
5,107
Operating Income or Loss
19,840
20,295
14,610
24,771
13,469
Interest Expense
3,436
3,169
3,322
4,024
6,252
Total Other Income/Expenses Net
-3,850
-1,138
8,958
227
-6,121
Income Before Tax
12,263
15,728
19,971
20,331
347
Income Tax Expense
1,620
2,712
6,303
4,255
-2,913
Income from Continuing Operations
10,642
13,016
13,668
16,076
3,260
Net Income
3,548
4,680
6,559
10,564
3,076
Net Income available to common shareholders
3,548
4,680
6,559
10,564
3,076
Reported EPS
Basic
-
0.06
0.09
0.15
0.04
Diluted
-
0.06
0.09
0.14
0.04
Weighted average shares outstanding
Basic
-
72,583
73,713
71,827
67,871
Diluted
-
74,085
75,486
74,204
70,772
EBITDA
-
50,383
47,098
39,288
13,458